Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 154 M140 M133 M149 M157 M 579 M Research & development ————— — Operating income 649 M417 M502 M542 M658 M 2.12 B Non-Operating Income, Total -271 M-164 M-216 M-212 M-249 M -841 M Interest expense, net of interest capitalized 238 M195 M243 M227 M279 M 944 M Non-Operating Income, excl. Interest Expenses -281 M-194 M-242 M-231 M-278 M -945 M Unusual income/expense 10 M30 M26 M19 M29 M 104 M Pretax income 378 M253 M286 M330 M409 M 1.28 B Equity in earnings ————— — Taxes 81 M55 M-7 M66 M93 M 207 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 297 M198 M293 M264 M316 M 1.07 B Discontinued operations ————— — Net income 297 M198 M293 M264 M316 M 1.07 B Dilution adjustment ———0— — Preferred dividends ———0— — Diluted net income available to common stockholders 297 M198 M293 M264 M316 M 1.07 B Basic earnings per share (Basic EPS) 0.450.30.450.410.48 1.64 Diluted earnings per share (Diluted EPS) 0.450.30.450.40.48 1.63 Average basic shares outstanding 652.16 M652.78 M652.86 M652.67 M653.42 M — Diluted shares outstanding 653.32 M654.04 M656.03 M655.65 M659.39 M — EBITDA 1.01 B787 M894 M947 M1.08 B 3.71 B EBIT 649 M417 M502 M542 M658 M 2.12 B Cost of revenue 1 M2 M1 M01 M 4 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 363 M370 M392 M405 M423 M 1.59 B